Fund Evaluator:
Unlimited HFGM Global Macro ETF (HFGM)
Follow This Fund
Alternative Strategies
Global Asset Class
Alternative
Fund Group
Macro Trading
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
1.01% F
Expense Ratio
$153 Mil
Assets
Open
Status
0.00%
12b-1 Fee
5.50%
TTM Yield
0.00%
Max Load
65%
Portfolio Turnover
Best Performing in Macro Trading Over the Last Year
| 22.8% | Dynamic Alpha Macro Institutional (DYMIX) |
| 13.6% | Quantified Alternative Investment Inv (QALTX) |
| -0.9% | AQR Macro Opportunities N (QGMNX) |
Data as of 7/31/2026
-0.3% C
1-Mo Return
-8.5% F
3-Mo Return
5.4% F
YTD Return
22.7% F
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Unlimited
Inception Date
4/14/2025
Share Class Type
Equity Investment Style
Large-Cap
Blend
Bond Investment Style
High Quality
Moderate Sensitivity
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
N/A: 100%
Additional Fund Details
Unlimited HFGM Global Macro ETF Overview
HFGM Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| HFGM Return (NAV) | -0.3% | -8.5% | 22.7% | na | na | na |
| HFGM Grade | C | F | F | na | na | na |
| +/- Category | -0.7% | -8.3% | 14.4% | na | na | na |
| Macro Trading Avg | 0.3% | -0.2% | 8.3% | 6.5% | 4.9% | 4.8% |
| HFGM Tax Cost Ratio | na | na | 4.0% | na | na | na |
HFGM Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| HFGM Return (NAV) | 5.4% | na | na | na | na | na | na | na | na | na | na |
| HFGM Grade | F | na | na | na | na | na | na | na | na | na | na |
| +/- Category | -0.0% | na | na | na | na | na | na | na | na | na | na |
| Macro Trading Avg | 5.4% | 6.6% | 6.5% | 4.4% | 4.4% | 2.8% | 4.4% | 8.9% | -0.5% | 6.7% | -0.8% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | High Quality Moderate Sensitivity |
| Yield: | 5.5% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $153 Mil |
| Fund Total Assets: | $ 154 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 65% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 1.3 years | |||
| Average Tenure: 1.3 years | |||
| Managers (Year): Elliott Bob (2025), McNevin Bruce (2025) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 38 |
| % in Top 10 Holdings: | 205.2% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 103.5% |
Portfolio Allocation |
|
| Domestic Stock: | 32.8% |
| Foreign Stock: | 55.5% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | -48.1% |
| Foreign Bond: | 48.0% |
| Convertible Bond: | 0.0% |
| Other: | 71.7% |
| Cash: | -59.9% |
Purchase Information
| Fund Family: | Unlimited |
| Phone Number: | 833-216-0499 |
| Website: |
| Status: | Open |
| Inception Date: | April 14, 2025 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 1.01% ( Rating : High ) |
| Category Average Expense Ratio (%): | 1.59% |
| Share Class: | Unlimited HFGM Global Macro ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.